GOG-3098 | TroFuse-20 Clinical Trial Update
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
GOG-3098 | TroFuse-20 Clinical Trial Update
-
Narrated by:
-
By:
In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer.
★ Support this podcast ★
adbl_web_anon_alc_button_suppression_t1
No reviews yet